atopica logo

ATOPICA® (cyclosporine capsules) USP MODIFIED

Captar Logo

Capstar® (nitenpyram)

Clomicalm Logo 4C 2016

Clomicalm® (clomipramine hydrochloride)

Comfortis Logo

Comfortis® (spinosad)

Deramaxx logo

Deramaxx® (deracoxib)

Galliprant Logo

Galliprant® (grapiprant tablets)

Interceptor® (milbemycin oxime)

Onsior logo

Onsior® Tablets for Dogs (robenacoxib)

onsior logo

Onsior® Injection (robenacoxib)

Osurnia® (florfenicol, terbinafine, betamethasone acetate)

PARASTAR Logo

Parastar® for Dogs

ParastarPLUS Logo

Parastar® Plus (fipronil/cyphenothrin)

Percorten-V Logo

Percorten®-V (desoxycorticosterone pivalate injectable suspension)

Placeholder until correct image

Rabvac®

Surolan Logo

Surolan® (miconazole nitrate, polymyxin B sulfate, prednisolone acetate)

Trifexis logo

Trifexis® (spinosad + milbemycin oxime)

Ultra Duramune logo

ULTRA™ Duramune®

Vetspon logo

Vetspon

Zobuxa logo

Zobuxa® (enrofloxacin)

onsior logo
Onsior® Injection (robenacoxib)

Help get them from hospital to home comfortably

With demonstrated efficacy for use up to a maximum of 3 days, Onsior should be your NSAID of choice for spay/neuter pain relief.

Onsior is an excellent option because it:

  • Ideal for spays and neuters
  • Rapidly absorbed and persists at the site of inflammation*1
  • Giving veterinarians the flexibility to transition a surgical patient from Onsior injection to sending home Onsior® (robenacoxib) Tablets for Dogs

    *clinical relevance unknown

    Click here to learn more

Indications

Onsior injection for dogs is indicated for the control of postoperative pain and inflammation associated with soft tissue surgery in dogs ≥ 4 months of age; for up to a maximum of 3 days.

Onsior Tablets for Dogs are approved for the control of postoperative pain and inflammation associated with soft tissue surgery in dogs ≥ 5.5 lbs (2.5 kg) and ≥ 4 months of age; for up to a maximum of 3 days.

Important Safety Information

Do not use in dogs that have a hypersensitivity to robenacoxib or known intolerance to NSAIDs. Not for use in humans. Keep this and all drugs out of reach of children and pets. Do not use for more than 3 days. Serious adverse events have been reported with long term use in dogs. All dogs should undergo a thorough history and exam before initiation of NSAID therapy. Appropriate testing should be conducted prior to administration of an NSAID. Owners should be advised to observe for signs of potential drug toxicity. Stop administration of ONSIOR if the dog experiences inappetence, vomiting or lethargy. Safe use has not been evaluated in dogs younger than 4 months of age, dogs used for breeding, or in pregnant or lactating dogs. Do not administer in conjunction with any other NSAID or corticosteroid. Click here for full prescribing information.

Onsior Injection: For subcutaneous use in dogs. Monitor dogs post-injection for reactions. Injection site reactions and anaphylactic reactions have been associated with the use of Onsior injection. Safety has not been demonstrated for intravenous or intramuscular administration. The most common adverse reactions were pain on injection, diarrhea and vomiting.

Onsior Tablet: For oral use in dogs only. Store out of reach of dogs and other pets in a secure location. Do not use in cats. Cats cannot be accurately dosed with the tablet sizes intended to be used in dogs. Dogs should weigh at least 5.5 lbs. The most commonly reported adverse reactions were diarrhea, vomiting, and decreased appetite.

Onsior is a trademark of Eli Lilly and Company or its affiliates.

1 Silber, H., Burgener, C., Letellier, I., et al. 2010. “Population pharmacokinetic analysis of blood and joint synovial fluid concentrations of robenacoxib from healthy dogs and dogs with osteoarthritis.” Pharm. Res. 27.12: 2633-2645.